Pain
-
In this study we compare the intrinsic characteristics and localization of nociceptive CO(2) laser evoked potential (LEP) and non-nociceptive electrical EP (SEP) sources recorded by deep electrodes (one to two electrodes per patient, 10-15 contacts per electrode) directly implanted in the supra-sylvian cortex of 15 epileptic patients. Early CO(2) laser (N140-P170) and electrical (N60-P90) evoked potentials were recorded by all of the electrodes implanted in the supra-sylvian cortex contralateral to stimulation. SEPs and LEPs had similar waveforms and inter-peak latencies. ⋯ The spatial distribution of these contralateral responses fits with that of the modeled sources of scalp CO(2) LEPs, magneto-encephalographic studies, and PET data from pain and vibrotactile activation studies. These results permit us to define the SII cortex as a cortical integration area of non-nociceptive and nociceptive inputs. This is supported by: (i) anatomical data reporting that the SII area receives inputs from both posterior columns and spino-thalamic pathways conveying the non-noxious and noxious information, respectively, and (ii) single cell recordings in monkeys, demonstrating that the SII area contains both nociceptive-specific neurons and wide-dynamic-range neurons receiving convergent input from nociceptive and non-nociceptive somatosensory afferents.
-
This study examined the relationship between pain self-efficacy beliefs and a range of pain behaviours, as measured by the pain behaviour questionnaire (PBQ), using a prospective design. A heterogeneous sample of 145 chronic pain patients completed sets of questionnaires on four occasions over a nine-month period. ⋯ These findings suggest that pain self-efficacy beliefs are an important determinant of pain behaviours and disability associated with pain, over and above the effects of pain, distress and personality variables. In particular, higher pain self-efficacy beliefs are predictive of reduced avoidance behaviours over an extended period.
-
Concussion, asphyxia, and systemically administered general anesthetics all induce reversible depression of the organism's response to noxious stimuli as one of the elements of loss of consciousness. This is so even for barbiturate anesthetics, which have only modest analgesic efficacy at subanesthetic doses. Little is known about the neural circuits involved in this form of antinociception, although for anesthetic agents, at least, it is usually presumed that the drugs act in widely distributed regions of the nervous system. ⋯ The behavioral suppression is accompanied by slow-wave EEG and, presumably, loss of consciousness. This zone, which we refer to as the mesopontine tegmental anesthesia locus (MPTA), apparently contains a barbiturate-sensitive 'switch' for both cortical and spinal activity. The very existence of the MPTA locus has implications for an understanding of the neural circuits that control motor functions and pain sensation, and for the cerebral representation of consciousness.